IL34 and neoplasm: In triple‐negative breast cancer (TNBC), Hippo–YAP/TAZ signaling enhances tumor‐associated macrophage (TAM) infiltration through the TAZ/IL‐34 axis, establishing an immunosuppressive environment that decreases the effectiveness of immune checkpoint therapies [84].